All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY2085 | Anti-MCPH1 (CBFYM-0611) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0611 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2086 | Anti-MCPH1 (CBFYM-1917) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-1917 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2087 | Anti-MCPH1 (CBFYM-1918) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-1918 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2088 | Anti-MCPH1 (CBFYM-1919) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-1919 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2089 | Anti-MCPH1 (CBFYM-1920) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Monkey | CBFYM-1920 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5338 | Anti-MCPH1 (CBFYM-0611) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0611 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5339 | Anti-MCPH1 (CBFYM-1917) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-1917 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5340 | Anti-MCPH1 (CBFYM-1918) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-1918 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5341 | Anti-MCPH1 (CBFYM-1919) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-1919 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5342 | Anti-MCPH1 (CBFYM-1920) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Monkey | CBFYM-1920 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION